Quarterly report pursuant to Section 13 or 15(d)

Segments (Tables)

v3.8.0.1
Segments (Tables)
9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Operations and Assets for Operating Segments and Geographic Information
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the three months ended September 30,
 
For the nine months ended September 30,
(In thousands)
2017
 
2016
 
2017
 
2016
Revenue from services:
 
 
 
 
 
 
 
Pharmaceutical
$

 
$

 
$

 
$

Diagnostics
229,035

 
259,025

 
740,992

 
777,559

Corporate

 

 

 

 
$
229,035

 
$
259,025

 
$
740,992

 
$
777,559

Revenue from products:
 
 
 
 
 
 
 
Pharmaceutical
$
22,795

 
$
20,569

 
$
73,992

 
$
63,275

Diagnostics

 

 

 

Corporate

 

 

 

 
$
22,795

 
$
20,569

 
$
73,992

 
$
63,275

Revenue from transfer of intellectual property:
 
 
 
 
 
 
 
Pharmaceutical
$
11,665

 
$
18,441

 
$
58,819

 
$
105,338

Diagnostics

 

 

 

Corporate

 

 

 

 
$
11,665

 
$
18,441

 
$
58,819

 
$
105,338

Operating loss:
 
 
 
 
 
 
 
Pharmaceutical
$
(18,452
)
 
$
(18,593
)
 
$
(49,709
)
 
$
15,422

Diagnostics
(27,619
)
 
3,098

 
(35,664
)
 
11,117

Corporate
(12,219
)
 
(8,128
)
 
(41,067
)
 
(49,414
)
 
$
(58,290
)
 
$
(23,623
)
 
$
(126,440
)
 
$
(22,875
)
Depreciation and amortization:
 
 
 
 
 
 
 
Pharmaceutical
$
6,935

 
$
6,994

 
$
20,404

 
$
12,841

Diagnostics
18,430

 
18,818

 
56,183

 
59,711

Corporate
29

 
20

 
90

 
60

 
$
25,394

 
$
25,832

 
$
76,677

 
$
72,612

Income (loss) from investment in investees:
 
 
 
 
 
 
 
Pharmaceutical
$
(3,661
)
 
$
399

 
$
(10,784
)
 
$
(5,643
)
Diagnostics
(352
)
 
(1,213
)
 
(987
)
 
496

Corporate

 

 

 

 
$
(4,013
)
 
$
(814
)
 
$
(11,771
)
 
$
(5,147
)
Revenues:
 
 
 
 
 
 
 
United States
$
229,218

 
$
259,221

 
$
751,732

 
$
777,703

Ireland
15,182

 
20,594

 
57,812

 
114,526

Chile
11,514

 
9,936

 
33,534

 
26,516

Spain
4,123

 
3,910

 
13,746

 
12,257

Israel
1,935

 
3,699

 
13,807

 
12,862

Mexico
1,483

 
675

 
3,072

 
2,308

Other
40

 

 
100



 
$
263,495

 
$
298,035

 
$
873,803

 
$
946,172


(In thousands)
September 30,
2017
 
December 31,
2016
Assets:
 
 
 
Pharmaceutical
$
1,309,650

 
$
1,294,916

Diagnostics
1,339,401

 
1,408,522

Corporate
72,939

 
63,181

 
$
2,721,990

 
$
2,766,619

Goodwill:

 

Pharmaceutical
$
262,786

 
$
251,817

Diagnostics
452,787

 
452,786

Corporate

 

 
$
715,573

 
$
704,603